nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
d-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia
|
Evins, A.Eden |
|
2002 |
56 |
1-2 |
p. 19-23 5 p. |
artikel |
2 |
Depression measures and motor side-effects in patients with acute schizophrenia
|
Kontaxakis, Vassilis P |
|
2002 |
56 |
1-2 |
p. 197-198 2 p. |
artikel |
3 |
Extreme weight gain in a youth with schizophrenia: risk/benefit considerations
|
Webster, Duncan |
|
2002 |
56 |
1-2 |
p. 187-189 3 p. |
artikel |
4 |
Independence and overlap among neurocognitive correlates of community functioning in schizophrenia
|
Dickinson, Dwight |
|
2002 |
56 |
1-2 |
p. 161-170 10 p. |
artikel |
5 |
Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders
|
de Leon, Jose |
|
2002 |
56 |
1-2 |
p. 47-54 8 p. |
artikel |
6 |
Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
|
Tuunainen, Arja |
|
2002 |
56 |
1-2 |
p. 1-10 10 p. |
artikel |
7 |
Olanzapine-associated type 2 diabetes mellitus
|
Opp, Deidre |
|
2002 |
56 |
1-2 |
p. 195-196 2 p. |
artikel |
8 |
PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component
|
Daneluzzo, E. |
|
2002 |
56 |
1-2 |
p. 129-136 8 p. |
artikel |
9 |
Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia
|
Voruganti, Lakshmi N.P |
|
2002 |
56 |
1-2 |
p. 37-46 10 p. |
artikel |
10 |
Positive and negative schizotypy in a student sample: neurocognitive and clinical correlates
|
Dinn, Wayne M |
|
2002 |
56 |
1-2 |
p. 171-185 15 p. |
artikel |
11 |
Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine
|
Markianos, M |
|
2002 |
56 |
1-2 |
p. 11-17 7 p. |
artikel |
12 |
Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital
|
de Leon, Jose |
|
2002 |
56 |
1-2 |
p. 55-65 11 p. |
artikel |
13 |
Serotonergic function and suicidal behavior in schizophrenia
|
Corrêa, Humberto |
|
2002 |
56 |
1-2 |
p. 75-85 11 p. |
artikel |
14 |
Sexual side effects of novel antipsychotic medications
|
Wirshing, Donna A |
|
2002 |
56 |
1-2 |
p. 25-30 6 p. |
artikel |
15 |
Smoking in schizophrenia — all is not biological
|
Srinivasan, T.N. |
|
2002 |
56 |
1-2 |
p. 67-74 8 p. |
artikel |
16 |
Social and clinical consequences of cognitive deficits in early psychosis: a two-year follow-up study of first-admitted patients
|
Verdoux, Hélène |
|
2002 |
56 |
1-2 |
p. 149-159 11 p. |
artikel |
17 |
Symptom patterns and subgrouping of schizophrenic patients: significance of negative symptoms assessed on admission
|
Hwu, Hai-Gwo |
|
2002 |
56 |
1-2 |
p. 105-119 15 p. |
artikel |
18 |
The characteristics of clozapine-induced fever
|
Jeong, Seong-Hoon |
|
2002 |
56 |
1-2 |
p. 191-193 3 p. |
artikel |
19 |
The dimensional symptom structure of schizophrenia and its association with temperament and character
|
Guillem, François |
|
2002 |
56 |
1-2 |
p. 137-147 11 p. |
artikel |
20 |
The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms
|
Möller, Hans-Jürgen |
|
2002 |
56 |
1-2 |
p. 87-94 8 p. |
artikel |
21 |
The relationship between positive symptoms and instrumental work functioning in schizophrenia: A 10year follow-up study
|
Racenstein, J.Meg |
|
2002 |
56 |
1-2 |
p. 95-103 9 p. |
artikel |
22 |
Typical antipsychotic drugs — D2 receptor occupancy and depressive symptoms in schizophrenia
|
Bressan, Rodrigo A |
|
2002 |
56 |
1-2 |
p. 31-36 6 p. |
artikel |
23 |
Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia
|
El Yazaji, Meriem |
|
2002 |
56 |
1-2 |
p. 121-127 7 p. |
artikel |